We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

244 hedge funds and large institutions have $1.3B invested in Collegium Pharmaceutical in 2025 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 84 increasing their positions, 87 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,158% more call options, than puts

Call options by funds: $478K | Put options by funds: $38K

105% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 21

23% more capital invested

Capital invested by funds: $1.06B → $1.3B (+$240M)

9% more funds holding

Funds holding: 223 → 244 (+21)

6.4% more ownership

Funds ownership: 111.08% → 117.48% (+6.4%)

3% less repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 87

Holders
244
Holders Change
+21
Holders Change %
+9.42%
% of All Funds
3.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
84
Reduced
87
Closed
21
Calls
$478K
Puts
$38K
Net Calls
+$440K
Net Calls Change
+$85K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$19.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$15.3M
3
Two Sigma Investments
Two Sigma Investments
New York
+$8.42M
4
Walleye Capital
Walleye Capital
New York
+$7.97M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$7.84M

Top Sellers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
-$11.5M
2
Invesco
Invesco
Georgia
-$10.5M
3
Bank of America
Bank of America
North Carolina
-$9.35M
4
EAM
Eventide Asset Management
Massachusetts
-$8.71M
5
JGC
J. Goldman & Co
New York
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
DMKJ
251
David M. Knott Jr
– -$695K -23,511 Closed
First Trust Advisors
252
First Trust Advisors
Illinois
– -$512K -17,307 Closed
AACP
253
Advantage Alpha Capital Partners
California
– -$459K -15,531 Closed
CL
254
Choreo LLC
Illinois
– -$336K -11,367 Closed
CC
255
Centiva Capital
New York
– -$334K -11,289 Closed
HighTower Advisors
256
HighTower Advisors
Illinois
– -$315K -10,657 Closed
Robeco Institutional Asset Management
257
Robeco Institutional Asset Management
Netherlands
– -$303K -10,237 Closed
MSRPS
258
Maryland State Retirement & Pension System
Maryland
– -$277K -9,383 Closed
VEA
259
Virtus ETF Advisers
New York
– -$104K -3,520 Closed
BIG
260
Brooklyn Investment Group
New York
– -$59.6K -2,015 Closed
RI
261
Ridgewood Investments
New Jersey
– -$5.91K -200 Closed
TPWA
262
Twin Peaks Wealth Advisors
California
– -$2.35K -62 Closed
LFG
263
Larson Financial Group
Missouri
– -$59 -2 Closed
SC
264
Stephens Consulting
Michigan
– -$30 -1 Closed
7 8 9 10
11

COLL Hedge Fund Activity: Q3 2025 in Review

244 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2025, worth a combined $1.3B — up 23% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new COLL positions and 21 closed out — a net gain of 22 holders — while 84 added to existing stakes and 87 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $19.7M. The largest seller was Rubric Capital Management (New York), cutting an estimated $11.5M.

  • 244 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2025, up from 223 in Q2 2025.
  • Funds reported $1.3B of Collegium Pharmaceutical stock for Q3 2025, up 23% quarter-over-quarter.
  • 43 funds opened new Collegium Pharmaceutical positions in Q3 2025 and 21 closed out, a net change of +22 holders.
  • The largest Collegium Pharmaceutical buyer in Q3 2025 was Goldman Sachs, an estimated $19.7M added.
  • The largest Collegium Pharmaceutical seller in Q3 2025 was Rubric Capital Management (New York), an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2025.